Reflections on the Implementation of Low-Dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain

Arch Bronconeumol. 2017 Oct;53(10):568-573. doi: 10.1016/j.arbres.2017.03.004. Epub 2017 Apr 14.
[Article in English, Spanish]

Abstract

Lung cancer (LC) is a major public health issue. Despite recent advances in treatment, primary prevention and early diagnosis are key to reducing the incidence and mortality of this disease. A recent clinical trial demonstrated the efficacy of selective screening by low-dose computed tomography (LDCT) in reducing the risk of both lung cancer mortality and all-cause mortality in high-risk individuals. This article contains the reflections of an expert group on the use of LDCT for early diagnosis of LC in high-risk individuals, and how to evaluate its implementation in Spain. The expert group was set up by the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Radiology (SERAM) and the Spanish Society of Medical Oncology (SEOM).

Keywords: Computed tomography; Cáncer de pulmón; Lung cancer; Radiografía; Radiography; Supervivencia; Survival; Tabaco; Tobacco; Tomografía Computarizada.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cost-Benefit Analysis
  • Early Detection of Cancer
  • Female
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / epidemiology
  • Male
  • Mass Screening / economics
  • Mass Screening / methods*
  • Middle Aged
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Quality-Adjusted Life Years
  • Risk
  • Sensitivity and Specificity
  • Solitary Pulmonary Nodule / diagnostic imaging
  • Spain / epidemiology
  • Tomography, X-Ray Computed / economics
  • Tomography, X-Ray Computed / methods*